Journal of Clinical Pediatrics ›› 2024, Vol. 42 ›› Issue (1): 53-57.doi: 10.12372/jcp.2024.22e0649
• Original Article • Previous Articles Next Articles
YAO Qianghua(
), WANG Yingchao, WANG Dao, LIU Yufeng
Received:2022-05-09
Published:2024-01-15
Online:2024-01-05
Contact:
YAO Qianghua
E-mail:yaoqianghua@126.com
YAO Qianghua, WANG Yingchao, WANG Dao, LIU Yufeng. Analysis of risk factors for early death of acute promyelocytic leukemia in children[J].Journal of Clinical Pediatrics, 2024, 42(1): 53-57.
"
| 临床特征 | 早期死亡组(n=13) | 生存组(n=90) | 统计量 | P |
|---|---|---|---|---|
| 男性[n(%)] | 10(76.9) | 46(51.1) | χ2=3.31 | 0.069 |
| 年龄[M(P25~P75)]/岁 | 11.0(6.5~12.5) | 9.0(7.0~14.0) | Z=0.25 | 0.799 |
| 初诊WBC[M(P25~P75)]×109·L-1 | 112.9(36.8~130.5) | 4.7(2.1~16.5) | Z=4.25 | <0.001 |
| 初诊WBC分组[n(%)] | - | <0.0011) | ||
| <10×109·L-1 | 1(7.7) | 64(71.1) | ||
| 10~20×109·L-1 | 1(7.7) | 5(5.6) | ||
| 20~50×109·L-1 | 3(23.1) | 10(11.1) | ||
| 50~100×109·L-1 | 1(7.7) | 5(5.6) | ||
| ≥100×109·L-1 | 7(53.8) | 6(6.7) | ||
| Hb(x±s)/g·L-1 | 71.0±22.7 | 73.6±19.3 | t=0.40 | 0.696 |
| PLT[M(P25~P75)]×109·L-1 | 18.0(12.0~24.0) | 21.0(13.0~44.0) | Z=1.12 | 0.264 |
| PT[M(P25~P75)]/s | 15.1(14.3~16.3) | 12.9(11.9~14.2) | Z=3.53 | <0.001 |
| PT延长≥3 s[n(%)] | 5(38.5) | 7(8.8) | χ2=10.39 | 0.001 |
| APTT[M(P25~P75)]/s | 27.2(24.7~28.9) | 29.1(25.6~32.2) | Z=1.52 | 0.129 |
| FIB[M(P25~P75)]/g·L-1 | 1.2(1.1~1.5) | 1.4(1.0~2.0) | Z=1.09 | 0.275 |
| D二聚体[M(P25~P75)]/mg·L-1 | 11.8(3.2~22.0) | 6.5(2.7~10.8) | Z=1.63 | 0.103 |
| D二聚体≥9 mg/L[n(%)] | 8(61.5) | 29(32.2) | χ2=4.24 | 0.039 |
| 骨髓早幼粒细胞[M(P25~P75)]/% | 95.0(92.0~96.0) | 90.0(82.0~95.0) | Z=2.59 | 0.010 |
| 骨髓早幼粒细胞≥90%[n(%)] | 12(92.3) | 45(50.0) | χ2=8.23 | 0.004 |
| FAB分型[n(%)] | χ2=0.10 | 0.758 | ||
| 经典型 | 12(92.3) | 85(94.4) | ||
| M3V | 1(7.7) | 5(5.6) | ||
| 危险度分层[n(%)] | - | <0.0011) | ||
| 低危 | 0(0.0) | 24(26.7) | ||
| 中危 | 1(7.7) | 40(44.4) | ||
| 高危 | 12(92.3) | 26(28.9) |
"
| 患儿 | 性别 | 年龄/岁 | 就诊时WBC×109·L-1 | 死亡时WBC×109·L-1 | 死亡时间 | 死亡原因 | 化 疗 |
|---|---|---|---|---|---|---|---|
| 例1 | 男 | 4 | 134.7 | 236.9 | d0 | ICH+PH | HU |
| 例2 | 女 | 7 | 19.6 | 62.9 | d4 | ICH | ATRA+HU |
| 例3 | 男 | 5 | 154.8 | 91.6 | d4 | ICH | ATRA+HU |
| 例4 | 男 | 12 | 48.4 | 318.6 | d6 | ICH+DS | ATRA+Ara-C |
| 例5 | 女 | 6 | 38.8 | 101.0 | d3 | ICH+PH+DS | ATRA+HU |
| 例6 | 男 | 11 | 1.9 | 1.2 | d0 | ICH+PH | 未化疗 |
| 例7 | 男 | 7 | 116.2 | 305.2 | d6 | ICH | ATRA+DNR |
| 例8 | 男 | 13 | 114.0 | 260.0 | d10 | ICH | ATRA+HU+Ara-C |
| 例9 | 女 | 14 | 126.4 | 126.5 | d1 | ICH+PH | ATRA+HU |
| 例10 | 男 | 11 | 112.9 | 421.7 | d8 | ICH+DS | ATRA+HU+Ara-C |
| 例11 | 男 | 10 | 187.9 | 71.5 | d12 | ICH+DS | ATRA+HU+Ara-C |
| 例12 | 男 | 12 | 34.8 | 247.2 | d5 | ICH | ATRA+Ara-C |
| 例13 | 男 | 13 | 96.0 | 150.4 | d4 | ICH+PH | ATRA+DNR |
| [1] |
Thomas X. Acute promyelocytic leukemia: a history over 60 years-from the most malignant to the most curable form of acute leukemia[J]. Oncol Ther, 2019, 7(1): 33-65.
doi: 10.1007/s40487-018-0091-5 |
| [2] |
Testi AM, D'Angiò M, Locatelli F, et al. Acute promyelocytic leukemia (APL): comparison between children and adults[J]. Mediterr J Hematol Infect Dis, 2014, 6(1): e2014032.
doi: 10.4084/mjhid.2014.032 |
| [3] |
Jillella AP, Kota VK. The global problem of early deaths in acute promyelocytic leukemia: a strategy to decrease induction mortality in the most curable leukemia[J]. Blood Rev, 2018, 32(2): 89-95.
doi: S0268-960X(17)30025-5 pmid: 29033137 |
| [4] | 中华医学会血液学分会, 中国医师协会血液科医师分会. 中国急性早幼粒细胞白血病诊疗指南(2018年版)[J]. 中华血液学杂志, 2018, 39(3): 179-183. |
| [5] |
Sanz MA, Lo Coco F, Martin G, et al. Definition of relapse risk and role of nonanthracyclinedrags for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups[J]. Blood, 2000, 96(4): 1247-1253.
pmid: 10942364 |
| [6] |
Gill H, Yung Y, Chu HT, et al. Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study[J]. Blood Adv, 2021, 5(14): 2829-2838.
doi: 10.1182/bloodadvances.2021004789 pmid: 34269798 |
| [7] |
Abla O, Ribeiro RC, Testi AM, et al. Predictors of thrombo hemorrhagic early death in children and adolescents with t (15; 17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy[J]. Ann Hematol, 2017, 96 (9): 1449-1456.
doi: 10.1007/s00277-017-3042-6 |
| [8] |
Dhakal P, Lyden E, Rajasurya V, et al. Early mortality and overall survival in acute promyelocytic leukemia: do real-world data match results of the clinical trials?[J]. Leuk Lymphoma, 2021, 62 (8): 1949-1957.
doi: 10.1080/10428194.2021.1894651 |
| [9] |
Nasir SS, Giri S, Nunnery S, et al. Outcome of adolescents and young adults compared with pediatric patients withacute myeloid and promyelocytic leukemia[J]. Clin Lymphoma Myeloma Leuk, 2017, 17(2): 126-132.
doi: 10.1016/j.clml.2016.09.011 |
| [10] |
de Azevedo AC, Matsuda E, Cervellini JY, et al. Early mortality in children and adolescents with acute promyelocytic leukemia: experience of the Boldrini children's center[J]. J Pediatr Hematol Oncol, 2020, 42(7): e641-e646.
doi: 10.1097/MPH.0000000000001601 |
| [11] |
Sanz MA, Montesinos P. Advances in the management of coagulopathy in acute promyelocytic leukemia[J]. Thromb Res, 2020, 191(Suppl 1): S63-S67.
doi: 10.1016/S0049-3848(20)30399-6 |
| [12] |
Mantha S, Goldman DA, Devlin SM, et al. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukaemia in the ATRA era[J]. Blood, 2017, 129(13): 1763-1767.
doi: 10.1182/blood-2016-10-747170 pmid: 28082441 |
| [13] |
Baysal M, Gürsoy V, Hunutlu FC, et al. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study[J]. Ann Hematol, 2022, 101(5): 1049-1057.
doi: 10.1007/s00277-022-04798-8 pmid: 35190843 |
| [14] |
Creutzig U, Zimmermann M, Dworzak M, et al. Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses[J]. Br J Haematol, 2010, 149(3): 399-409.
doi: 10.1111/bjh.2010.149.issue-3 |
| [15] |
Zhang ZX, Lu AD, Wu J, et al. Retrospective analysis of data from 73 patients with childhood acute promyelocytic leukaemia receiving modified chemotherapy: a single-centre study[J]. J Cancer Res Clin Oncol, 2021, 147(4): 1189-1201.
doi: 10.1007/s00432-020-03406-4 |
| [16] | 王静, 贾月萍, 刘桂兰, 等. 不同方案诱导治疗儿童急性早幼粒细胞白血病的临床分析[J]. 临床儿科杂志, 2014, 32(5): 405-409. |
| [17] | 张丽, 竺晓凡. 我如何治疗儿童急性早幼粒细胞白血病[J]. 中华血液学杂志, 2020, 41(10): 793-797. |
| [18] |
Hou J, Wang S, Zhang Y, et al. Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide[J]. Ann Hematol, 2017, 96(12): 2005-2013.
doi: 10.1007/s00277-017-3130-7 pmid: 28940056 |
| [19] | Ciftciler R, Haznedaroglu IC, Aksu S, et al. The factors affecting early death in newly diagnosed APL patients[J]. Open Med (Wars), 2019, 14: 647-652. |
| [20] |
Hou W, Zhang Y, Jin B, et al. Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone[J]. Blood Cells Mol Dis, 2019, 79: 102351.
doi: 10.1016/j.bcmd.2019.102351 |
| [1] | LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689. |
| [2] | ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697. |
| [3] | ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704. |
| [4] | WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711. |
| [5] | WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720. |
| [6] | HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726. |
| [7] | SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732. |
| [8] | Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608. |
| [9] | Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621. |
| [10] | LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627. |
| [11] | WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635. |
| [12] | GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643. |
| [13] | YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650. |
| [14] | HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488. |
| [15] | LIU Ziyao, WANG Congying, WANG Hongmao, ZHANG Mingming, XU Yingjie, LAI Jianming, NIU Wenquan, LI Xiaohui. Early differentiation of Kawasaki disease with joint symptoms and systemic juvenile idiopathic arthritis with Kawasaki disease-like symptoms: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(6): 489-498. |
|
||